Advertisement

Journal of Economics and Finance

, Volume 28, Issue 3, pp 395–403 | Cite as

The impact of nicotine replacement therapies on cigarette demand

  • Frank J. Chaloupka
  • John A. Tauras
Article

Abstract

Over the past 20 years, several nicotine replacement therapies (NRTs) have been approved for use as smoking cessation aids, with over-the-counter use of these products approved beginning in 1996. To date, only one econometric study has examined the impact of NRT on cigarette demand, providing limited evidence that the availability of these products has reduced cigarette demand. This paper adds to this limited literature by examining the impact of NRT availability, pricing, and use on U.S. cigarette demand, concluding that NRT is a substitute for cigarettes and that the elasticity of cigarette demand with respect to NRT sales is-0.06.

Keywords

Nicotine Nicotine Replacement Therapy Tobacco Control Nasal Spray Nicotine Patch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bolton, Lisa E., Joel B. Cohen, and Paul N. Bloom. 2004. “The Marketing of ‘Get Out of Jail Free Cards’: How Remedies Encourage Risky Consumption.” Working Paper, Department of Marketing, University of Pennsylvania. www-marketing.wharton.upenn.edu/ideas/pdf/ Bolton/Marketing%20of%20Get%20Out%20of%20Jail%20Free.pdf.Google Scholar
  2. Centers for Disease Control and Prevention. 2002. “Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Economic Costs—United States, 1995–1999.”Morbidity and Mortality Weekly Report 51 (14): 300–303.Google Scholar
  3. Centers for Disease Control and Prevention. 2004a. “Early Release of Selected Estimates Based on Data from the January–September 2003 National Health Interview Survey”. www.cdc.gov/nchs/about/major/nhis/released200403.htm.Google Scholar
  4. Centers for Disease Control and Prevention. 2004b. “Percentage of Adults Who Were Current, Former, or Never Smokers, + Overall and by Sex, Race, Hispanic Origin, Age, and Education, National Health Interview Surveys, Selected Years—United States, 1965–2000.” www.cdc.gov/tobacco/research_data/adults_prev/adstatl.htm.Google Scholar
  5. Centers for Disease Control and Prevention. 2004c. “State Medicaid Coverage for Tobacco-Dependence Treatments—United States, 1994–2002.”Morbidity and Mortality Weekly Report, 53(3):54–57.Google Scholar
  6. Chaloupka, Frank J. In Press. “Taxation as a Public Health Strategy.”Annual Review of Public Health.Google Scholar
  7. Chaloupka, Frank J., and Kenneth E. Warner 2000. “The Economics of Smoking.” InHandbook of Health Economics, edited by Anthony J. Cuyler and Joseph P. Newhouse. New York North-Holland.Google Scholar
  8. Chandra, Siddharth, and Frank J. Chaloupka 2003. “Seasonality in Cigarette Sales: Patterns and Implications for Tobacco Control.”Tobacco Control 12: 105–107.CrossRefGoogle Scholar
  9. Curry, Susan J., Louis C. Grothaus, Tim McAfee, and Chester Pabiniak 1998. “Use and Cost Effectiveness of Smoking-Cessation Services Under Four Health Insurance Plans in a Health Maintenance Organization.”New England Journal of Medicine 339: 673–679.CrossRefGoogle Scholar
  10. Farrelly, Matthew C., Terry F. Pechacek, and Frank J. Chaloupka. 2003. “The Impact of Tobacco Control Program Expenditures on Aggregate Cigarette Sales: 1981–2000.”Journal of Health Economics 22: 843–859.CrossRefGoogle Scholar
  11. Fiore, Michael C., William C. Bailey, Stuart J. Cohen, Sally Faith Dorfman, Michael G. Goldstein, Ellen R. Gritz, Richard B. Heyman, Carlos Robert Jaen, Tomas E. Kottke, Harry A. Lando, Robert E. Mecklenburg, Patricia Dolan Mullen, Louise M. Nett, Lawrence Robinson, Maxine L. Stitzer, Anthony C. Tommasello, Louise Villejo, and Mary Ellen Wewers. 2000.Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service.Google Scholar
  12. Fitchenberg, Caroline M., and Stanton A. Glantz. 2002. “Effects of Smoke-Free Workplaces on Smoking Behaviour: Systematic Review.”British Medical Journal 325: 188–191.CrossRefGoogle Scholar
  13. Hu, Teh-Wei, Hai-Yen Sung, Theodore E. Keeler, and Martin Marciniak. 2000. “Cigarette Consumption and Sales of Nicotine Replacement Products.”Tobacco Control 9(S2): ii60-ii63.Google Scholar
  14. Hughes, John R., Saul Shiffman, and Junji Zhang. 2003. “A Meta-analysis of the Efficacy of Over-the-Counter Nicotine Replacement.”Tobacco Control 12: 21–27.CrossRefGoogle Scholar
  15. Mokdad, Ali H., James S. Marks, Donna F. Stroup, and Julie L. Gerberding. 2004. “Actual Causes of Death in the United States, 2000,”Journal of the American Medical Association 291: 1238–1245.CrossRefGoogle Scholar
  16. Physicians' Desk Reference (2001). Medical Economics Company, Thompson Healthcare Publishing. 55: 3056–3057.Google Scholar
  17. Shiffman, Saul, Jean A. Paty, Jeffey M. Rohay, Michael E. DiMarino, and Joe Gitchell. 2000. “The Efficacy of Computer-Tailored Smoking Cessation Material, as a Supplement to Nicotine Polacrilex Gum Therapy.”Archives of Internal Medicine 160: 1675–1681.CrossRefGoogle Scholar
  18. Tauras, John A., and Frank J. Chaloupka. 2003. “The Demand for Nicotine Replacement Therapies.”Nicotine & Tobacco Research, 5: 237–243.CrossRefGoogle Scholar
  19. Tauras, John A., and Frank J. Chaloupka. 2004. “Nicotine Patches and Gum: Economic Complements or Substitutes?” Working Paper, Department of Economics, University of Illinois at Chicago.Google Scholar
  20. Tauras, John A., Frank J. Chaloupka, and Sherry L. Emery. 2003. “Nicotine Replacement Therapy Demand: The Impact of Prices and Advertising.” Working Paper, Department of Economics, University of Illinois at Chicago.Google Scholar
  21. U.S. Department of Health and Human Services. 2000. “Reducing Tobacco Use: A Report of the Surgeon General.” Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.Google Scholar
  22. Warner, Kenneth E., and Erika G. Martin. 2003. “The U.S. Tobacco Control Community's View of the Future of Tobacco Harm Reduction.”Tobacco Control 13: 383–390.CrossRefGoogle Scholar
  23. Warner, Kenneth E., John Slade, and David T. Sweanor. 1997. “The Emerging Market for Long-Term Nicotine Maintenance.”Journal of the American Medical Association 278: 1087–1092.CrossRefGoogle Scholar

Copyright information

© Academy of Economics and Finance 2004

Authors and Affiliations

  • Frank J. Chaloupka
    • 1
  • John A. Tauras
    • 1
  1. 1.Department of Economics (m/c 144)University of Illinois at ChicagoChicago

Personalised recommendations